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Purpose: Pulmonary rehabilitation (PR) enhances exercise tolerance in patients with COPD; 
however, improvements in physical activity (PA) are not guaranteed. This study explored the 
relationship between baseline exercise tolerance and changes in PA after PR.
Materials and methods: Patient data from prospective clinical trials in the PR settings 
of Athens and Leuven (2008–2016) were analyzed. Validated PA monitors were worn for 1 
week before and after a 12-week program. The proportion of patients who improved PA levels 
$1,000 steps/day (“PA responders”) after PR was compared between those with initial 6-minute 
walk distance [6MWDi] ,350 m and $350 m. Baseline predictors of PA change were evaluated 
via univariate and multivariate logistic regression analyses.
Results: Two hundred thirty-six patients with COPD (median [IQR] FEV
1
 44 [33–59] % 
predicted, age 65±8 years, 6MWDi 416 [332–486] m) were included. The proportion of “PA 
responders” after PR was significantly greater in those with higher vs lower 6MWDi (37.9% 
vs 16.4%, respectively; P,0.001). 6MWDi group classification was the strongest baseline 
independent predictor of PA improvement (univariate OR 3.10, 95% CI 1.51–6.36).
Conclusion: The likelihood of improving PA after PR is increased with greater 6MWDi. 
Baseline exercise tolerance appears as an important stratification metric for future research in 
this field.
Keywords: exercise and pulmonary rehabilitation, COPD, physical activity, clinical respiratory 
medicine, responder analysis
Plain language summary
Why was the study done? Some people with COPD improve physical activity (PA) levels 
after pulmonary rehabilitation while others do not. We wanted to test whether we could better 
identify who would or would not respond in terms of their PA levels by looking at their baseline 
exercise tolerance levels.
What did the researchers do and find? We used a common threshold (350 m) for a 
6-minute walk test to classify people as having low or high exercise tolerance and explored 
how well this related to PA responses. Those in the low group were very unlikely to improve 
PA, while some of those in the high group improved PA. Classifying patients according to 
this threshold proved a useful way to predict PA responses, especially when applied as a 
“rule-out” test.
What do these results mean? The 350 m threshold is a useful way to identify people who 
are not likely to improve PA after pulmonary rehabilitation. Attempts to improve PA levels 
should be targeted toward those with high baseline exercise tolerance, but additional factors 
are likely to influence the likelihood of achieving such gains.
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Introduction
Deficits in exercise tolerance and physical activity (PA) are 
common features of COPD associated with increased risk of 
morbidity and mortality.1–3 Enhancement of exercise toler-
ance and PA is the primary goal of pulmonary rehabilitation 
(PR).4 While comprehensive PR is one of the most effective 
interventions to improve exercise tolerance in COPD,5 its 
impact on PA is less clear. Considerable interest surrounds 
the potential for PR to improve PA; however, clinical data 
demonstrate large heterogeneity regarding the magnitude and 
consistency of its effects in this patient group.6–9
Changes in PA may be underpinned by different 
mechanisms8,10 and may or may not occur in conjunction 
with improvements in exercise tolerance.9 For example, 
changes in PA levels have been previously shown to only 
weakly correlate with changes in exercise tolerance,9,11 while 
a recent systematic review demonstrated only small (effect 
size 0.12, n=7 studies) mean improvements in PA levels after 
exercise training.7 There is therefore a need to more closely 
examine the effects of PR on PA in specific COPD patient 
subgroups. Recent findings from a large international tele-
coaching program in patients with COPD suggest that larger 
changes in PA occur in those with more preserved baseline 
functional exercise tolerance.10 This is consistent with the 
concept of “functional reserve”:12,13 that those with high toler-
ance to exercise may have greater opportunity to be physi-
cally active within their tolerance limits (ie, high functional 
reserve), whereas those with low tolerance to exercise may 
be less capable of increasing PA levels due to an inhibitory 
ceiling limitation (ie, low functional reserve). Concurrent 
improvements in exercise tolerance would appear essential 
in this latter instance, while an absence of PA improvement 
in the former group could signify the presence of challenging 
behaviors potentially inhibiting PA adaptations, as has been 
previously suggested.14
Identification of patients with greater potential to 
improve PA is an important step to tailor future personal-
ized PR approaches to the right individuals and optimize 
its potential modulating effects on PA. If exercise toler-
ance is to be a clinically useful stratification parameter 
for this purpose, it is important to explore the utility of an 
ideal “cutoff.” The 6-minute walk test (6MWT) is one of 
the most commonly used clinical tests for assessing exer-
cise tolerance in the field of PR.15 The most widely used 
threshold for this test in patients with COPD is 350 m due 
to its well-recognized prognostic importance via the BODE 
index – a multidimensional composite index used to evaluate 
mortality risk in this patient group.16,17 The importance of 
this stratification metric for determining changes in PA after 
PR has not been determined. This study aimed to determine 
whether the likelihood of improving PA levels following PR 
is related to underlying exercise tolerance. We hypothesized 
that, in line with the functional reserve concept, patients 
with poorer initial exercise tolerance would be less likely 
to improve PA levels after PR than those with better initial 
exercise tolerance.
Materials and methods
Design
This study was a secondary, pooled analysis of data from 
five prospective, registered clinical trials conducted across 
University Hospital Gasthuisberg (Leuven, Belgium) and 
Sotiria and Evangelismos Hospitals (Athens, Greece) 
between December 2008 and June 2016. All patients pro-
vided written informed consent for their respective studies, 
and the present study was approved by the human ethics 
committee of University Hospital, Leuven (S60558). All 
patients with a confirmed clinical and spirometric diagnosis 
of COPD18 who completed PR and had available baseline 
and 3 month PA data were eligible for inclusion in this 
pooled analysis.
Procedure
Participants underwent detailed clinical assessments before 
and after PR, including lung function (spirometry, gas 
transfer, lung volumes), maximal respiratory pressures 
(maximal inspiratory pressure, maximal expiratory pressure), 
quadriceps muscle force (maximal voluntary contraction 
via Biodex [Leuven] and strain gauge [Athens]), quality of 
life (Chronic Respiratory Disease Questionnaire [CRDQ]), 
dyspnea (Medical Research Council [MRC] dyspnea 
scale), and exercise tolerance (6MWT and cycle ergometer 
cardiopulmonary exercise test [CPET]). The 6MWT was 
performed according to ATS/ERS standards15 on a quiet 
indoor walking track; however, the length differed between 
sites (50 m for Leuven, 30 m for Sotiria Hospital, and 18 m 
for Evangelismos Hospital). Participants were encouraged 
to walk as far as possible with close therapist supervision. 
The test was performed twice at the same site with best dis-
tance recorded. PA levels were monitored for 1 week before 
and after PR with one of the following activity monitors 
validated for patients with COPD (same monitor used pre- 
and post-PR for each individual): DynaPort MoveMonitor 
(DAM, McRoberts BV, The Hague, the Netherlands; n=57 
at Leuven), Actigraph (ACT, ActiGraph LLC Pensacola, 
FL, USA; n=123 across Athens and Leuven), or SenseWear 
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Pro Armband (BodyMedia version 6.0, Inc., Pittsburgh, PA, 
USA; n=56 at Leuven). Choice of monitor was determined 
by study protocol at each center. PA data were validated in 
accordance with the criteria proposed by Demeyer et al19 
($4 week/days, $8 hours/day) and used to derive a weekly 
average steps/day. Hours of daylight were used as a proxy to 
account for seasonality effects that may alter opportunities 
to be physically active.20
The programs at each center comprised comprehensive, 
interdisciplinary PR that has been previously described.21–23 
In brief, this comprises high-intensity whole body exercise 
training, strength training, lower and upper limb endurance 
training, and education. No specific cointerventions were 
provided to explicitly target improvements in PA levels. 
One included study (NCT00948623) had a PA counseling 
intervention arm; however, PA outcome data did not differ 
between groups. Another study (NCT02618746) had a 
home-based telerehabilitation intervention arm; however, 
randomization for this study commenced after the initial 
hospital-based PR. The site at Leuven conducted both cycle 
ergometry and treadmill walking training, while the sites 
in Athens implemented cycle ergometry only. Patients 
attended three sessions per week for 3 months (primary 
study endpoint), however were also invited to continue 
2 days per week for three additional months (usual clinical 
care at these sites).
analysis
Full clinical data to characterize the samples and evaluate 
responses to PR were collected using standardized extrac-
tion templates and inspected for normality via frequency 
histograms and Shapiro–Wilk statistic. Continuous 
variables were expressed as means with standard devia-
tion (SD) when normally distributed or as medians [25th 
to 75th percentile] when non-normally distributed, unless 
stated otherwise. Demographic data and PR responses 
were compared between sites and mean initial 6-minute 
walk distance (6MWDi) was compared between both Athens 
centers to explore variability related to differing corridor 
lengths. The principal study analyses were conducted as 
one pooled cohort.
For the primary analysis, participants were categorized 
according to 6MWDi as having low (,350 m) or high 
($350 m) exercise tolerance. The proportion of patients who 
improved PA after PR was compared across the 6MWDi 
groups via chi-squared test according to two separate analyses 
defined according to the attainment or not of common clinical 
targets: (primary definition) $1,000 steps/day improvement 
(defined as the minimally important difference [MID])24 and 
(secondary definition) attainment of a “fairly active” level of 
PA ($7,000 steps/day)25 after PR.
Pearson correlation coefficients were calculated to assess 
the association between changes in PA and both 6MWDi 
and 6MWD change. The magnitude of change in PA (mean 
steps/day) was compared between groups (6MWDi ,350 m 
vs 6MWDi $350 m) via unpaired t-tests and represented via 
dot plot and XY coordinate arrow plot.
A “responder analysis” was conducted to identify differ-
ences in patient characteristics between PA “responders” and 
“nonresponders” after PR, based on the 1,000 steps/day PA 
change cutoff via unpaired t-tests or Mann–Whitney tests 
(for parametric or nonparametric data). Logistic regression 
analysis was performed to explore the usefulness of 6MWDi 
category as a predictor of “PA responder” status (yes/no). 
Baseline demographic factor variables hypothesized to 
potentially contribute to change in PA following PR (FEV
1
% 
predicted, functional residual capacity % predicted, quality 
of life, dyspnea level, quadriceps force, body mass index, 
and baseline PA level) were examined as potential covariates 
for this analysis in addition to fixed variables of PR site, PA 
monitor type, and change in hours of daylight from baseline 
to 3 months. Each factor was first entered into a univariate 
model, and in the absence of collinearity (comparable eigen-
values, variance inflation factor ,10) those found to be sig-
nificant (P#0.20) were entered into a multivariate model. 
Receiver operator curve (ROC) analysis was conducted to 
ascertain the sensitivity and specificity of the 350 m 6MWDi 
cutoff to detect “PA responders” and estimate the area under 
the curve (AUC).
Sensitivity analyses were conducted to explore the robust-
ness of findings related to the proportion of “PA responders.” 
This comprises repeat chi-squared analyses using a) the same 
1,000 steps/day definition of a “PA responder” but CPET-
derived measures of relative, weight-adjusted peak oxygen 
consumption; b) the lower and upper limits of the MID for 
PA change after PR (cutoffs of 600 and 1,100 steps/day, 
respectively); and c) exclusion of the top 5% extreme PA 
values (further details in Supplementary material). Mean 
change in PA was also compared across 6MWDi groups 
defined according to 6MWDi quartiles and evaluated via 
one-way ANOVA. Findings were compared between data 
expressed in “absolute” native units (steps/day) vs “relative” 
percent change from baseline due to uncertainty regarding 
the clinical importance of the latter approach. Statistical 
significance was denoted by P-values ,0.05 for all analyses 
unless otherwise stated.
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Results
Data were available from 241 patients upon completion of 
PR (152 Leuven, 89 Athens; Figure 1). Five patients were 
excluded (three from Leuven, two from Athens) due to PA 
data failing to meet validation criteria. Baseline character-
istics of the 236 included participants are listed in Table 1. 
Small, but statistically significant differences were observed 
between participants of Leuven and Athens in terms of 
gender, body mass index, quality of life, lung function, and 
6MWD. Participants were generally inactive at the start of 
PR (median [IQR] 3,920 [2,295–5,804] steps/day). No differ-
ences were observed in mean 6MWDi between participants 
of the Athens sites that used the 30 m (n=69) or 18 m (n=18) 
corridor lengths (P=0.740). PR was highly effective across 
a range of clinical outcomes (Table S1).
The proportion of “PA responders” (.1,000 steps/day 
change after PR) was significantly greater in those with 
6MWDi $350 m compared with those with 6MWDi ,350 m 
(37.9% vs 16.4%, respectively; P=0.001; Table 2; Figure 2). 
The proportion of patients deemed “fairly active (mean $7,000 
steps/day)” at 3 months was also greater in patients with better 
6MWDi (23.7% vs 4.5%, respectively; P=0.001). This repre-
sented a modest positive shift from baseline (17.2% vs 4.5%, 
respectively), with 58.1% of patients maintaining a “fairly 
active” status from baseline. The vast majority (91.2%) of the 
204 patients deemed “fairly inactive (,7,000 steps/day)” at 
baseline remained “fairly inactive” at 3 months.
Both 6MWDi and change in 6MWD correlated signifi-
cantly but weakly with change in PA (r=0.205 and 0.217, 
respectively; Figures S1 and S2). Mean (SD) changes in 
PA levels from baseline to 3 months were small overall 
(551±1,770 steps/day; P,0.001). Mean (SD) magnitude of 
change in PA levels (mean steps/day) according to the low 
and high 6MWDi groups was 157 (1,694) and 707 (1,780), 
respectively (P=0.031 between-groups; Figure 3).
“PA responders” were found to have slightly better 
lung function, less dyspnea, better quality of life and more 
preserved exercise capacity (VO
2
peak), quadriceps muscle 
force, and 6MWT at baseline compared with “PA nonre-
sponders” (P,0.05 for all; Table 2). The sole factor related 
to PR training responses that differed between these two 
groups was magnitude of improvement in 6MWD. While 
both groups experienced clinically relevant improvements 
in 6MWD, “PA responders” experienced 15.8 m more mean 
improvement than nonresponders (P=0.042).
Table 3 lists the findings of the logistic regression analysis. 
Multivariate analysis revealed 6MWDi group classification to 
be the only significant independent baseline predictor of PA 
improvement after PR, adjusted for change in daylight.
ROC analysis confirmed 350 m was a useful 6MWDi 
cutoff of high negative predictive value. Those with 
6MWDi ,350 m were highly unlikely to achieve gains in 
PA $1,000 steps/day (85.3% sensitivity). Specificity was, 
however, relatively low (34.8%), resulting in an AUC of 
0.662 (Figure S3). Sensitivity analyses revealed similar 
findings to the principal analysis across the three explor-
atory comparisons. By contrast, findings were not replicable 
when data were expressed as percent change from baseline 
(Figures S4 and S5). Further details of the sensitivity analyses 
are given in the Supplementary material.
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Figure 1 CONSORT diagram of patient flow through the study.
Abbreviations: n, number of participants; Pa, physical activity; Pr, pulmonary rehabilitation.
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Discussion
Findings from this multicenter study conducted in two 
countries highlight that clinically important improvements 
in PA after PR are much (three-fold [OR {95% CI}=3.10 
{1.51–6.36}]) more likely to occur in COPD patients with 
better preserved baseline exercise tolerance (6MWDi $350 m). 
The result appears consistent with CPET-derived measures of 
VO
2
peak (Supplementary material), and sensitivity analyses 
Table 1 Baseline demographic characteristics of participants with valid Pa assessments (by site)
Participant characteristics N Total (n=236) N Leuven (n=149) N Athens (n=87) P-value
age, years 236 65±8 149 65±7 87 65±9 0.66
gender (male/female), n 236 178/58 149 103/46 87 75/12 0.003
BMI, kg/m2 236 25 [22–29] 149 25 [21–29] 87 27 [24–30] ,0.001
BMI $30, n (%) 236 56 (23.7) 149 34 (22.8) 87 22 (25.3) 0.67
FeV1, l 236 1.21 [0.89–1.65] 149 1.10 [0.88–1.48] 87 1.45 [0.98–1.89] 0.002
FeV1, % predicted 236 44.3 [33.0–59.0] 149 41.5 [32.6–54.0] 87 51 [33–64] 0.06
gOlD stage (I/II/III/IV), n 236 10/83/100/43 149 7/43/70/29 87 3/40/30/14 0.07
TlCO, % predicted 220 50.0 [39.0–65.2] 133 45.5 [37.1–58.9] 87 57 [43–73] ,0.001
MrC score 185 3 [2–4] 98 3 [2–4] 87 3 [2–4] 0.12
CrDQtotal 216 81 [69–94] 129 78 [67–88] 87 88 [76–108] ,0.001
6MWDi group $350 m, n (%) 236 169 (71%) 149 110 (74%) 87 59 (68%) 0.32
6MWD, m 236 416 [332–486] 149 426 [333–500] 87 392 [332–454] 0.04
VO2 peak, ml/kg/min 235 15.1 [12.6–17.9] 148 15.5 [12.1–19.8] 87 15.0 [13.8–17.6] 0.45
Physical activity, steps/day 236 3,920 [2,295–5,804] 149 3,902 [2,326–5,493] 87 4,014 [2,287–6,260] 0.70
Physical activity .7,000 m (n, %) 236 32 (13.6%) 149 21 (14.1%) 87 11 (12.6%) 0.75
Quadriceps force, nm 228 116.2±40.6 141 110.0±33.9 87 126.2±48.2 0.05
Notes: Data are median [IQr] or mean ± sD unless otherwise stated. P-values refer to comparisons between leuven and athens sites. Bold values denote statistical 
significance.
Abbreviations: 6MWD, six-minute walk distance; 6MWDi, initial six-minute walk distance; BMI, body mass index; CrDQ, Chronic respiratory Disease Questionnaire; FeV1, 
forced expiratory volume in the first second; GOLD, Global burden Of Lung Disease; MRC, Medical Research Council dyspnea scale (score range 1–5); Nm, newton-meters; 
Pa, physical activity; TlCO, transfer factor for carbon monoxide.
Table 2 Characteristics of “Pa responders” (.1,000 steps/day) vs “nonresponders”
Participant characteristics N “PA responder” N “PA nonresponder” P-value
age 75 64.4±7.3 161 65.5±8.0 0.29
BMI 75 25 [22–28] 161 25 [22–30] 0.73
FeV1, % predicted 75 50.8±15.9 160 44.8±17.6 0.012
TlC, % predicted 75 112.4±16.9 157 119.8±22.7 0.013
FrC, % predicted 75 150.9±39.1 155 164.8±41.9 0.017
TlCO, % predicted 74 54.8±19.2 146 52.3±18.0 0.35
MrC score 59 3 [2–3] 126 3 [3–4] 0.024
CrDQtotal 72 87.6±21.4 151 79.5±18.5 0.004
Physical activity, steps/day 75 4,210±2,488 161 4,222±2,526 0.97
6MWDi group (,350 m/$350 m), n 75 11/64 161 56/105 0.001
6MWDi, m 75 444±103 161 382±115 ,0.001
VO2peak (ml/kg/min) 75 16.8±3.9 160 14.8±3.9 ,0.001
Wmax 75 70.7±27.2 160 58.2±23.6 ,0.001
Quadriceps force, nm 71 126.1±40.1 157 111.7±40.1 0.012
Δ FeV1, % predicted 75 -0.02±5.94 156 0.21±5.55 0.78
Δ CrDQdyspnea 72 5.7±5.2 142 4.9±5.1 0.27
Δ CrDQtotal 65 15.9±11.5 135 14.3±11.9 0.37
Δ 6MWD, m 75 57.2±67.6 156 41.4±47.7 0.042
6MWD responders .30 m (n, %) 75 52 (69.3%) 156 98 (62.8%) 0.33
Δ VO2peak (ml/kg/min) 74 1.13±3.00 146 1.37±2.75 0.55
Δ Quadriceps force (nm) 71 16.5±23.9 153 13.5±15.1 0.27
Notes: Data are median [IQr] or mean ± SD. Bold font denotes statistical significance; Dashed line separates baseline and change (Δ) variables.
Abbreviations: 6MWD, six-minute walk distance; 6MWDi, initial six-minute walk distance; BMI, body mass index; CrDQ, Chronic respiratory Disease Questionnaire; 
FeV1, forced expiratory volume in the first second; FRC, functional residual capacity; MRC, Medical Research Council dyspnea scale (score range 1–5); Nm, newton-meters; 
Pa, physical activity; TlC, total lung capacity; TlCO, transfer factor of carbon monoxide.
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suggest that the phenomenon is quite robust across different 
PA change thresholds. Our data affirm the clinical relevance 
of the 350 m cutoff threshold, previously demonstrated for 
the outcome of mortality by work of our group17 and others,16 
by highlighting its novel application as a useful “rule out” 
test to identify patients unlikely to experience meaningful 
increases in PA after PR (6MWDi ,350 m, sensitivity 85%; 
Figure S3). It is interesting to observe that the small propor-
tion of patients (13%) who improved PA after PR from this 
subgroup did so only in conjunction with quite dramatic 
changes in 6MWD (mean [SD] change in 6MWD in the 
11 responders with low 6MWDi 128.4 [98.3] m). Attempts 
to enhance PA do not therefore appear to be the best focus 
of rehabilitation for these patients but may be considered 
a more appropriate long-term goal after exercise tolerance 
has been regained.
The higher likelihood of PA improvement in patients 
who entered PR with a more preserved exercise tolerance 
suggests this COPD subgroup may be a good target for 
tailored PA cointerventions during PR. The best adjunct 
therapy to achieve this aim is not yet clear, due in part to 
uncertainty regarding the precise factors that likely influ-
ence PA participation. For example, in addition to baseline 
exercise tolerance, it is reasonable to expect PA responses 
to be mediated by personal motivations, self-efficacy, and 
willingness to change. If patients are properly selected on 
the basis of preserved functional and/or peak exercise toler-
ance, one might speculate that interventions grounded in 
behavioral therapies could be appropriate.26 The provision 
of coaching-based interventions founded upon motivational 
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principles but without self-monitoring and feedback has 
been shown to be insufficient to improve PA after PR.27 The 
addition of self-monitoring and goal setting with feedback, 
however, has been shown to be somewhat more effective, 
with one small study demonstrating mean improvements in 
the magnitude of 3,278 steps/day.28 Interestingly, this strategy 
was recently found to be unsuccessful in more symptomatic 
patients with poor exercise tolerance,29 which might be 
anticipated from our findings.
Our data concur with that of a recent large, multicenter 
international study from the PROactive consortium10 that 
found a 3-month semiautomated telecoaching intervention 
to be effective at changing PA. This study did not run con-
currently with PR; however, exploratory post hoc analyses 
revealed patients with higher 6MWD, lower symptom score 
(mMRC), and those in Global burden Of Lung Disease 
(GOLD) A-B (vs C-D) at baseline achieved gains of a greater 
magnitude than those observed in the present rehabilitation 
study. Considered together, this suggests hidden potential for 
PR to positively influence PA in COPD subgroups defined 
according to baseline exercise tolerance. Comparisons of 
treatment effectiveness according to such parameters are 
currently rare. It is therefore plausible that potentially useful 
data regarding adjunct strategies applied during PR exist but 
remain concealed by a lack of stratification. The interaction 
between exercise tolerance and its ability to modulate PA 
responses during PR may shed new light on some of the early 
hypotheses that proposed such coexistent aims posed inherent 
“competing agendas.”30 As significant interest surrounds 
the identification of the best candidates for interventions 
targeting improvements in PA levels, we expect consider-
ation of baseline exercise tolerance to feature prominently 
in future studies of this nature.
Limitations
The three PA monitors used in this pooled analysis have 
known differing accuracy to detect step counts in patients 
with COPD.31 Their combined use, however, was controlled 
for in the regression models without evident systematic bias 
(Table 3). Exploratory analysis of the principal outcome 
within individual PA monitor subgroups revealed a consis-
tently lower proportion of responders to PR in patients with 
6MWDi ,350 m compared with those with 6MWDi $350 m; 
however, significance was only reached for the Actigraph, 
which had the most available data (n=123) compared with 
the DynaPort (n=52) and SenseWear (n=56). Our study also 
included sites where the 6MWT was performed on tracks of 
differing lengths. While site did not emerge as a significant pre-
dictor in the univariate logistic regression analysis, we do not 
advocate for the 6MWT to be conducted on shorter (,30 m) 
track lengths nor confirm that our findings should be expected 
to occur reliably if testing were conducted in such environ-
ments. Finally, the extent to which the factors investigated 
in this study relate to the maintenance phase following PR 
completion was not explored, meaning their relevance beyond 
the point of PR completion should be inferred with caution.
Conclusion
The likelihood of improving PA following PR is significantly 
higher in patients with COPD who have greater baseline 
Table 3 logistic regression analysis to predict physical activity “responders” (Δ1,000 steps/day) at 3 months
Predictors Univariate Multivariate
OR (95% CI) P-value OR (95% CI) P-value
6MWDi ,350 m (reference) – – – –
6MWDi $350 m 3.10 (1.51–6.36) 0.002 3.25 (1.12–9.40) 0.030
CrDQtotal 1.02 (1.01–1.04) 0.005 1.02 (1.00–1.03) 0.080
FeV1, % predicted 1.02 (1.00–1.04) 0.013 1.02 (0.99–1.04) 0.198
MrC dyspnea 0.67 (0.49–0.93) 0.015 1.00 (0.66–1.51) 0.990
Quadriceps force, nm 1.01 (1.00–1.02) 0.015 1.01 (1.00–1.01) 0.189
FrC, % predicted 0.99 (0.98–1.00) 0.019 0.99 (0.98–1.00) 0.218
Body mass index 0.97 (0.93–1.03) 0.388
Baseline physical activity (steps/day) 1.00 (1.00–1.00) 0.973
Δ daylight hours 1.00 (1.00–1.00) 0.009 1.00 (1.00–1.00) 0.018
site: leuven (reference)
athens
–
1.12 (0.64–1.97)
–
0.695
Pa monitor: DynaPort (reference)
actigraph
senseWear
–
0.97 (0.48–1.96)
1.35 (0.61–3.00)
–
0.928
0.462
Notes: Bold font denotes statistical significance; – denotes reference group.
Abbreviations: 6MWDi, initial six-minute walk distance; BMI, body mass index; CrDQtotal, Chronic respiratory Disease Questionnaire Total score; FeV1, forced expiratory 
volume in the first second; FRC, functional residual capacity; MRC, Medical Research Council dyspnea scale (score range 1–5); PA, physical activity.
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functional exercise tolerance ($350 m on 6MWT) com-
pared with those with lower levels. Baseline 6MWDi status 
is a strong, independent predictor of change in PA after 3 
months of PR. Enhancing PA may be an unrealistic goal in 
patients with poor exercise tolerance. Future studies seek-
ing to improve PA in patients with COPD may benefit from 
targeting those with higher baseline exercise tolerance or 
stratifying analyses according to this important parameter.
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Supplementary materials
sensitivity analyses
For the purpose of sensitivity analysis, chi-squared analy-
ses were repeated for the primary outcome using 1) the 
same 1,000 steps/day definition of a physical activity (PA) 
responder but cardiopulmonary exercise test (CPET)-derived 
measures of relative peak oxygen consumption (VO
2
peak 
adjusted for weight) instead of initial 6-minute walk distance 
(6MWDi) (groups defined by cutoff at the 28th percentile – 
corresponding to the proportions obtained via 6MWDi); 
2) the lower and upper limits of the minimally important dif-
ference [MID] for PA change after pulmonary rehabilitation 
(PR) (cutoffs of 600 and 1,100 steps/day, respectively); and 
3) exclusion of the top 5% extreme PA values. Mean change 
in PA was also compared across groups defined according to 
6MWDi quartiles and evaluated via one-way ANOVA.
In line with findings of the 6MWDi, 16.7% of patients 
with a low baseline weight-adjusted VO
2
peak (,13.042 
mL/min/kg, derived from maximal incremental cycle CPET 
[corresponding to the 28th percentile of 6MWDi]), achieved 
an improvement of $1,000 steps/day compared with 37.9% 
of patients who had a more preserved baseline VO
2
peak 
(P=0.002). This pattern was weaker when VO
2
peak was 
expressed in absolute units (28th percentile correspond-
ing to ,0.930 L/min), with the proportion of respond-
ers being 27.3% vs 33.7% for the low and high groups, 
respectively (P=0.34).
The proportion of patients who improved PA by 
the suggested lower (600 steps/day) and upper limit 
(1,100 steps/day) of the MID in PA at 3 months increased 
significantly with increased 6MWDi (respectively, 25.4% vs 
50.9% for 6MWDi ,350 m; P,0.001 and 4.9% vs 36.1% 
for 6MWDi $350 m; P=0.001). 
The sensitivity analysis relating to the exclusion of the top 
5% outlying PA data resulted in proportions of responders in 
the 6MWDi ,350 m vs 6MWDi $350 m of 16% and 35%, 
respectively (P=0.005).
The mean [SD] magnitude of change in PA (steps/
day) across the groups defined according to 6MWDi 
quartiles increased significantly with increasing 6MWDi 
(99 [1,750], 336 [1,468], 525 [1,444], 1,245 [2,152] for 
Q1–4, respectively; P=0.003). In contrast to the principal 
analysis, when PA change was expressed as a percent-
age change from baseline, no significant differences were 
observed in the magnitude of PA change across either the 
two 6MWDi groups (18.3 [109], 31.4 [78.7] for ,350 m 
and $350 m groups; P=0.306) or the groups defined accord-
ing to 6MWDi quartiles (17.9 [114.8], 37.2 [104.7], 23.7 
[58.6], 32.2 [61.1] for Q1–4, respectively; P=0.642; Figures 
S4 and S5). All chi-squared analyses conducted using dif-
ferent thresholds of relative PA improvement (10%, 15%, 
20% change from baseline) for the two 6MWDi groups 
were nonsignificant.
Table S1 Pulmonary rehabilitation responses
Participant characteristics Total (n=236) Leuven (n=149) Athens (n=87) P-value
Δ FeV1, % predicted 0 [-1.6–1.36] 0.0 [-4.0–4.0] 0.0 [0.0–0.0] 0.82
Δ CrDQ total 13 [7–21] 18 [10–25] 10 [6–14] ,0.001
Δ 6MWD, m 41 [23–72] 48 [20–83] 38 [25–52] 0.15
6MWD responders (Δ.30 m), n (%) 150 (65)* 92 (64)* 58 (67) 0.67
Δ VO2peak, ml/kg/min 1.23 [0.19–2.38] 0.92 [-0.83–2.77] 1.33 [0.93–1.89] 0.03
Δ Quadriceps force, nm 14.4±18.4 13.3±21.1 16.3±12.9 0.09
Δ Physical activity, mean steps/day 551±1,770 592±1,861 480±1,612 0.64
Pa responders (Δ.1,000 steps/day), n (%) 75 (32) 46 (31) 29 (33) 0.70
Notes: Data are median [IQr] or mean ± SD. Bold font denotes statistical significance between the two sites. *3-month 6MWD data unavailable for five participants at 
leuven site.
Abbreviations: Δ, change; 6MWD, six-minute walk test distance; BMI, body mass index; CrDQ, Chronic respiratory Disease Questionnaire; FeV1, forced expiratory 
volume in the first second; m, meters; Nm, newton-meters; PA, physical activity.
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Figure S1 Pearson correlation between 6MWDi and change in Pa (steps/day).
Notes: Proportion of Pa responders, according to 6MWDi groups (vertical dashed line), denoted by the ratio of dots above vs below the horizontal dashed line. 
The horizontal dashed line represents a change in Pa of more than 1,000 steps/day.
Abbreviations: 6MWDi, initial 6-minute walk distance; Pa, physical activity.
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Figure S2 Pearson correlation between changes in Pa levels and changes in exercise tolerance at 3 months.
Notes: Closed circles represent patients with 6MWDi of ,350 m; open circles represent patients with 6MWDi of at least 350 m. horizontal dashed line represents the 
proposed minimally important difference threshold for improvement in Pa after Pr (1,000 steps/day).
Abbreviations: 6MWDi, initial 6-minute walk distance; Pa, physical activity; Pr, pulmonary rehabilitation.
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Figure S3 rOC curve of 6MWDi cutoff to identify Pa responder.
Notes: Arrow denotes 350 m cutoff reference value corresponding with 85.33% sensitivity; 34.78% specificity; 50.85% correctly classified; +ve likelihood ratio 1.308; -ve 
likelihood ratio 0.422.
Abbreviations: 6MWDi, initial 6-minute walk distance; Pa, physical activity; rOC, receiver operator curve.
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Figure S4 Changes in physical activity across the two 6MWDi groups, expressed as percent change from baseline.
Notes: horizontal bars denote group means. Percentage change derived from mean steps/day weekly count. horizontal dashed lines represent the point of zero change.
Abbreviation: 6MWDi, initial 6-minute walk distance.
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Figure S5 Changes in physical activity across 6MWDi quartiles.
Notes: (A) Change in physical activity expressed as steps/day. (B) Change in physical activity expressed as percent change from baseline, derived from mean steps/day weekly 
count. horizontal dashed lines represent the point of zero change. P-value denotes result from one-way anOVa test.
Abbreviation: 6MWDi, initial 6-minute walk distance.
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